GSK plc ADR sell Barclays PLC
Start price
20.02.26
/
50%
€50.50
Target price
20.02.27
-
Performance (%)
-14.06%
Price
06.08.26
€45.40
Summary
This prediction is currently active. The price of GSK plc ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.06%. This prediction currently runs until 20.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | 0.442% | 0.442% |
| iShares Core DAX® | 2.573% | 3.502% |
| iShares Nasdaq 100 | 4.858% | 0.654% |
| iShares Nikkei 225® | 5.590% | -0.246% |
| iShares S&P 500 | 3.250% | 2.083% |
Comments by Barclays_PLC for this prediction
In the thread GSK plc ADR diskutieren
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for GSK provided by MarketBeat